System for direct and rapid AST dRAST

dRAST, direct & Rapid Antimicrobial Susceptibility Test

 

dRAST provides MIC-based phenotypic antimicrobial susceptibility testing direct from positive blood culture in as low as 4 hours; reducing time to results by up to 2 days compared to conventional method. The rapid results allow for earlier optimization of antibiotics in critically-ill patients with bloodstream infections and sepsis.

 

• Dedicated to positive blood culture samples

• Provides phenotypic MIC in as low as 4 hours

• Random access with up to 12 samples simultaneously (15 panel positions)

• Expert system on board with choice of guidelines

• Easy start with no McFarland required, no sample prep

• 2 panels: 1 Gram Neg. + 1 Gram Pos.

• Easy to use, fast to operate

• No daily maintenance

 

2 days faster than conventional AST

 

Conventional AST from blood can take at least three days or longer to produce results, as bacteria first has to be detected in blood and a pure isolate obtained before AST can proceed. dRAST, on the other hand, utilizes microfluidic technology and microscopic imaging technology that eliminates the need for pure isolate, to enable much faster results that can impact optimize antibiotic prescribing sooner.

 

dRAST Kit

 

dRAST test kit consists of Panel, Agarose, and Broth.

 

Gram-positive and Gram-negative panels using either CLSI or EUCAST recommended antimicrobials and breakpoints are available for dRAST.

CLSI panel: 17 Gram-positive , 19 Gram-negative antibiotics with multiple concentrations

EUCAST panel: 18 Gram-positive , 17 Gram-negative antibiotics with multiple concentrations